Taxane and platinum-based chemotherapeutic agent
This page covers all Taxane and platinum-based chemotherapeutic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Microtubules and DNA.
Targets
Phase 3 pipeline (1)
- Taxanes plus Carboplatin · Shanghai Jiao Tong University School of Medicine · Oncology
Taxanes work by inhibiting microtubule dynamics, disrupting cell division, and inducing apoptosis in cancer cells. Carboplatin works by crosslinking DNA, causing cell death in rapidly dividing cancer cells.
Phase 2 pipeline (1)
- CCRT with weekly docetaxel & cisplatin · Samsung Medical Center · Oncology
Docetaxel inhibits microtubule dynamics, disrupting cell division, while cisplatin induces DNA crosslinks, causing cell death.
Patent intelligence
- taxane and platinum based chemotherapeutic agent patent landscape — aggregated cliff calendar, attackable patents, originator estates